跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEMERIN COUGH SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
SEMERIN COUGH SYRUP
Approved
THERAPEUTIC
SEMERIN COUGH SYRUP
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
May 25, 1989
Approval ID
64630686618f9ea0
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
64630686618f9ea0
Drug Name
SEMERIN COUGH SYRUP
Product Name
SEMERIN COUGH SYRUP
Approval Number
SIN03526P
Approval Date
1989-05-25
Registrant
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Licence Holder
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05CA10
Atc Item Name
combinations
Pharma Manufacturer Name
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Active Ingredients
SODIUM CITRATE
150 mg/5 ml
EPHEDRINE HCl
4 mg/5 ml
AMMONIUM CHLORIDE
100 mg/5 ml
AMMONIUM CHLORIDE
100 mg/5 ml
EPHEDRINE HCl
4 mg/5 ml
SODIUM CITRATE
150 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 25, 1989
Approval ID
64630686618f9ea0
Type
Therapeutic
Back to HSA Approvals